We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FERG:NYSEFerguson Enterprises Inc. Analysis

Data as of 2026-05-25 - not real-time

$223.31

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ferguson Enterprises is trading below its short‑term moving averages, with the 20‑day SMA sitting above the 50‑day SMA, indicating a mild bullish bias that has yet to materialize in price. The RSI is firmly in oversold territory while the MACD histogram remains negative, suggesting short‑term momentum weakness but also potential for a reversal. Volume is on an upward trend, and the beta above one points to heightened sensitivity to market moves, compounded by elevated 30‑day volatility. Dividend news adds a catalyst: the board declared a $0.89 per share payout, with a payout ratio near one‑third, reinforcing the appeal for income‑focused investors.
On the valuation side, the discounted cash flow model places fair value well below the current market price, and price‑to‑book is considerably high relative to peers, flagging the stock as overvalued. Margins are modest and free cash flow is currently zero, while total debt exceeds cash, raising concerns about balance‑sheet leverage. Nevertheless, operating cash flow remains positive and the dividend appears sustainable. The combination of an overvalued price, solid dividend, and sector resilience suggests a cautious stance, with opportunities mainly for short‑term traders looking to capture a potential bounce off support.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Oversold RSI indicating potential upside
  • Upcoming dividend payout provides immediate yield
  • Support level near recent lows offers downside protection

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Fundamentals show modest revenue growth and stable margins
  • Valuation remains above intrinsic estimates
  • Sustainable dividend supports total return

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt relative to cash creates balance‑sheet risk
  • Sector provides defensive exposure to essential infrastructure
  • Dividend yield and payout ratio remain attractive over time

Key Metrics & Analysis

Financial Health

Revenue Growth3.60%
Profit Margin6.30%
P/E Ratio22.0
Debt/Equity103.52
P/B Ratio7.4
Op. Cash Flow$2.0B
Industry P/E29.7

Technical Analysis

TrendBullish
RSI32.6
Support$214.44
Resistance$268.67
MA 20$242.50
MA 50$241.50
MA 200$239.99
MACDBearish
VolumeIncreasing
Fear & Greed Index91.8

Valuation

Fair Value$80.35
Target Price$284.57
Upside/Downside27.43%
GradeOvervalued
TypeBlend
Dividend Yield1.59%

Risk Assessment

Beta1.21
Volatility26.06%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.